Ascorbic acid, rutoside drug combination
Product Specifications
CAS Number
8067-12-7
Target
Others
Related Pathways
Others
Bioactivity
Ascorbic acid, rutoside drug combination is used for treating diabetic retinopathy.
Smiles
[C@@H](CO)(O)[C@@]1(C(O)=C(O)C(=O)O1)[H].O(C1=C(OC=2C(C1=O)=C(O)C=C(O)C2)C3=CC(O)=C(O)C=C3)[C@@H]4O[C@H](CO[C@H]5[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O5)[C@@H](O)[C@H](O)[C@H]4O
Molecular Formula
C33H38O22
Molecular Weight
786.64
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6441389-01 0.1 mL
TP53BP1 (Tumor Protein 53 Binding Protein 1, p53-Binding Protein 1, 53BP1, FLJ41424, MGC138366, p202) (PE)
Sign In for Pricing
View Details MBS6441389-02 5x 0.1 mL
TP53BP1 (Tumor Protein 53 Binding Protein 1, p53-Binding Protein 1, 53BP1, FLJ41424, MGC138366, p202) (PE)
Sign In for Pricing
View Details 
GTR15143886 1 Vial
Lentiviral human NDUFV3 shRNA (UAS) - Lentiviral human NDUFV3 shRNA (UAS) (100)
Sign In for Pricing
View Details